MEDICAL TREATMENT CLOTHING PREVENTING THE PATIENT FROM REACHING THE WOUND FOLLOWING OPERATION AND INJURY

Abstract

The invention relates to a medical treatment clothing used following surgical operation on domestic animals in case of injury, which prevents the animal from reaching the wound, and therefore enables the animal to return to its routine life in short time. The invention particularly relates to production of fabrics comprising Polyamide or Polyester yarns made of filament fibers and 2-50% polyurethane fibers known as Lycra for medical treatment clothing, and to the production method thereof.

Claims

1. The invention is a medical treatment clothing used following surgical operation on animals in case of injury, in order to prevent the animal from reaching the wound, and therefore ensure that the animal returns to its routine life in short time, and it is characterized in that; it comprises a fabric comprising yarns made of filament fibers, raw material which is not found in nature, and which is derived from synthesis of petroleum and hard coal, and 2-50% polyurethane fibers.

2. The invention is a production method of a medical treatment clothing used following surgical operation on domestic animals in case of injury, in order to prevent the animal from reaching the wound, and therefore ensuring that the animal returns to its routine life in short time, and it is characterized in that; it comprises the operation steps of: combining yarns made of filament fibers via synthesis from petroleum and hard coal with polyurethane yarns, placing the fabric obtained as a result of the combining process and the dye and finishing to be applied into hot water and allowing binding of the fabric to the dye and the finishing for 40 to 90 minutes, drying the final fabric, smoothing the final fabric, conditioning the fabric for 24-48 hours at room temperature, cutting the fabric, stitching the fabric, and forming the final state of the medical treatment clothing.

3.-4. (canceled)

5. The fabric according to claim 2, and it is characterized in that; where in said the combining of yarns made of filament fibers via synthesis from petroleum and hard coal with polyurethane yarns with polyurethane fibers is performed by knitting operation.

6.-7. (canceled)

8. The finishing applied in claim 2, and it is characterized in that; where in said the finishing is antimicrobial-antiallergic finishing.

9. The antimicrobial and anti-allergic finishing according to claim 2 or claim 8, and it is characterized in that; it comprises silver nitrate.

10.-11. (canceled)

12. The finishing applied in claim 2, and it is characterized in that; where in said the finishing is water repellent and water tightness finishing.

13. (canceled)

14. The finishing applied in claim 2, and it is characterized in that; where in said the finishing is ectoparasitary chemical finishing.

15. (canceled)

16. The finishing applied in claim 2, and it is characterized in that; where in said the finishing is dirtproof and stainproof finishing.

17. (canceled)

18. The finishing applied in claim 2, and it is characterized in that; where in said the finishing is bitterness finishing.

19. (canceled)

20. The finishing applied in claim 2, and it is characterized in that; where in said the finishing is antifungal finishing.

21. (canceled)

22. The fabric according to claim 1 or claim 2, and it is characterized in that; where in said the fabric comprises micro capsules that contact the animal and that are applied to the inner part.

23.-27. (canceled)

28. The fabric according to claim 1 or claim 2, and it is characterized in that; it comprises application of film lamination on mentioned fabric in order to provide the fabric with resistance during complete covering of the fabric, waterproofing of the fabric, and applications of tension, stretching, and lateral forces on the fabric.

29. (canceled)

30. The medical treatment clothing production method according to claim 2, and it is characterized in that; where in said the stitches are left at the outer part of the medical treatment clothing.

31. (canceled)

32. The medical treatment clothing production method according to claim 2, and it is characterized in that; where in said the stitching method is in conformity with the elastane structure of the fabric and it is single needle zigzag lock stitch, which eliminates the tearing risk of the stitch.

Description

DETAILED DESCRIPTION OF THE INVENTION

[0030] The invention is a medical treatment clothing used following surgical operation on animals in case of injury, prevents the animal from reaching the wound, and therefore enables the animal to return to its routine life in short time. The most important element in the invention is the fabric of medical treatment clothing. This fabric comprises Polyamide or Polyester yarns made of filament fibers, raw material of which is not found in nature, and which is derived from synthesis of petroleum and hard coal, and 2-50% polyurethane fibers known as Lycra. The fabric is obtained by combining any one of the polyamide or polyester yarns with polyurethane yarns. Combination process is performed in knitting and weaving machinery. The knitting technique used while knitting the fabric is rachel knitting technique, and this is done by interlock knitting method.

[0031] After the fabric is obtained, the fabric becomes a printed fabric by a variety of printing techniques via dyeing one side of the fabric with figures, patterns, and texture themes using dye. Or, the dye is attached to the fabric by keeping under water by using dyes in dyeing kiers at 50 C. for at least 40 to 90 minutes. Silver Nitrate, Citric Acid, etc. components that are relevant chemicals as antimicrobial-antiallergic finish are added to the kier during attachment of the dye to the fabric. In addition, Ag.sup.+, Cu.sup.+2, Zn.sup.+2 Cations can also be used. As another finishing, fluorocarbon-based water repellent finishing agent is used as water repellent and waterproof finish. Permethrin is used as ectoparasitary chemical finishing; Fluorocarbon-based substance as dirt-proof and stain-proof finishing; tabasco and its essences as bitterness finishing; inorganic salts (Ag.sup.+, Cu.sup.+2, Zn.sup.+2) and surfactant agents as antifungal finishing. Also, microcapsules are positioned inside the fabric; and for this purpose, the microcapsules prepared with Antibiotics (Rifamycin, etc.), Zn-containing wound powders, Antiseptics (Iodine preparates, etc.), and natural and synthetic flowers essences with pleasant odor are integrated and attached to the fabric at different treatment phases through various methods. When these processes are completed, the fabric is dried and smoothened by being passed through hot-rolls under a certain tension. The fabric obtained is wrapped in rolls and conditioned for 24-48 hours at room temperature.

[0032] On the conditioned fabrics, film lamination is applied, which has a standard not to impair the elastane rate of the fabric, ensures liquid-tightness on one surface of the fabric or between two fabrics, covers the whole fabric, does not lose its texture integrity and does not become deformed in applications of tension, stretching, and lateral forces. Hotmelt type lamination technique is applied in order to prevent the fabric from losing its flexibility. Lamination is made by applying bonding process in the range of 100-110 C. While there may be one layer of film and one layer of fabric at the lamination step, there may also be a middle layer of film on the exterior surfaces of both fabrics.

[0033] Laminated, finished, dyed, treated, or printing processed fabric product is ready for cutting and processing.

[0034] The stitches should be on the exterior surface during production in order not to irritate the body. Surplus parts of the fabric should be out of the body and on the exterior surface, or the ends of the fabrics should be knitted by putting them directly against each other. However, it must be noted that the stitching technique used in knitting or stitching conforms to the elastane property of the fabric. The stitches surrounding the product should be elastane in proportion to fabric, so that the fabric is not resistant to elastane property. For this purpose, preferably, single needle zigzag lock stitching is used. With this method, the tearing risk of the stitch is eliminated, and maximum conformity is ensured between the stitch and elastane property of the fabric. Binding made of elastane fabric, patters with elastane property, and coverstitch can also be used.